目的 建立西維來司他鈉的藥物利用評價(jià)（DUE）標(biāo)準(zhǔn)，應(yīng)用加權(quán)TOPSIS法評價(jià)其臨床應(yīng)用的合理性，為臨床合理使用西維來司他鈉提供參考。方法 以西維來司他鈉藥品說明書、相關(guān)共識等為參考，制定西維來司他鈉合理用藥評價(jià)標(biāo)準(zhǔn)。根據(jù)制定的標(biāo)準(zhǔn)，利用PASS系統(tǒng)抽取2023年1月—12月六安市人民醫(yī)院使用西維來司他鈉的128份住院患者的病例信息，并采用加權(quán)TOPSIS法對抽取的病歷進(jìn)行分析，評價(jià)用藥合理性。結(jié)果 西維來司他鈉完全符合評價(jià)標(biāo)準(zhǔn)的病例有63例（49.2%），用藥不適宜主要表現(xiàn)在適應(yīng)證43例（33.6%）、輔助檢查及實(shí)驗(yàn)室檢查27例（21.1%）、用法用量18例（14.1%）、用藥療程18例（14.1%）、不良反應(yīng)10例（12.8%）。通過加權(quán)TOPSIS法，判定為合理用藥83例（64.8%），基本合理用藥5例（3.9%），不合理用藥40例（31.3%）。結(jié)論 通過建立西維來司他鈉臨床應(yīng)用的合理性評價(jià)標(biāo)準(zhǔn)，發(fā)現(xiàn)西維來司他鈉臨床使用合理率占比較高，但仍存在使用不合理現(xiàn)象，通過前置審方系統(tǒng)完善西維來司他鈉用藥規(guī)則，促進(jìn)藥物合理、規(guī)范使用。

Objective To establish the criteria for drug utilization evaluation (DUE) of sivelestat sodium, and apply the weighted TOPSIS method to evaluate the rationality of its clinical application, so as to provide reference for rational clinical use of sivelestat sodium. Methods The evaluation criteria for rational drug use of sivelestat sodium were established with reference to the drug instructions and relevant consensus of sivelestat sodium. According to the established criteria, the data of 128 inpatients using cilvelestat sodium in Lu’an People’s Hospital from January to December 2023 were extracted by the PASS system, and the extracted medical records were analyzed by weighted TOPSIS method to evaluate the rationality of drug use. Results There were 63 cases (49.2%) in which sivelestat sodium fully met the evaluation criteria. The inappropriateness of medication was mainly manifested in: There were 43 cases (33.6%) of indications, 27 cases (21.1%) of auxiliary examination and laboratory examination, 18 cases (14.1%) of usage and dosage, 18 cases (14.1%) of treatment course, and 10 cases (12.8%) of adverse reactions. By weighted TOPSIS method, 83 cases (64.8%) were judged to be rational drug use, 5 cases (3.9%) were basically rational drug use, and 40 cases (31.3%) were irrational drug use. Conclusion Through the establishment of rational evaluation criteria for clinical application of sivelestat sodium, it can be seen from the results that the rational rate of clinical use of sivelestat sodium is relatively high, but there are still irrational use. The pre-review prescription system is used to improve the medication rules of sivelestat sodium, and promote the rational and standardized use of drugs.

R974

安徽省教育廳高?？茖W(xué)研究項(xiàng)目（KJ2021A0342）